Request for Covid-19 Impact Assessment of this Report
The United States Androgenic Alopecia Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Androgenic Alopecia Therapeutics market, reaching US$ million by the year 2028. As for the Europe Androgenic Alopecia Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Androgenic Alopecia Therapeutics players cover Johnson & Johnson, Merck, GlaxoSmithKline, and Astellas Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgenic Alopecia Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Medicine
Surgery
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy's Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Androgenic Alopecia Therapeutics Market Size 2017-2028
2.1.2 Androgenic Alopecia Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Androgenic Alopecia Therapeutics Segment by Type
2.2.1 Medicine
2.2.2 Surgery
2.2.3 Other
2.3 Androgenic Alopecia Therapeutics Market Size by Type
2.3.1 Androgenic Alopecia Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Androgenic Alopecia Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Androgenic Alopecia Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Androgenic Alopecia Therapeutics Market Size by Application
2.5.1 Androgenic Alopecia Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Androgenic Alopecia Therapeutics Market Size Market Share by Application (2017-2022)
3 Androgenic Alopecia Therapeutics Market Size by Player
3.1 Androgenic Alopecia Therapeutics Market Size Market Share by Players
3.1.1 Global Androgenic Alopecia Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Androgenic Alopecia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Androgenic Alopecia Therapeutics by Regions
4.1 Androgenic Alopecia Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Androgenic Alopecia Therapeutics Market Size Growth (2017-2022)
4.3 APAC Androgenic Alopecia Therapeutics Market Size Growth (2017-2022)
4.4 Europe Androgenic Alopecia Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Androgenic Alopecia Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Androgenic Alopecia Therapeutics Market Size by Country (2017-2022)
5.2 Americas Androgenic Alopecia Therapeutics Market Size by Type (2017-2022)
5.3 Americas Androgenic Alopecia Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgenic Alopecia Therapeutics Market Size by Region (2017-2022)
6.2 APAC Androgenic Alopecia Therapeutics Market Size by Type (2017-2022)
6.3 APAC Androgenic Alopecia Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Androgenic Alopecia Therapeutics by Country (2017-2022)
7.2 Europe Androgenic Alopecia Therapeutics Market Size by Type (2017-2022)
7.3 Europe Androgenic Alopecia Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Androgenic Alopecia Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Androgenic Alopecia Therapeutics Market Forecast
10.1 Global Androgenic Alopecia Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Androgenic Alopecia Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Androgenic Alopecia Therapeutics Forecast
10.1.3 APAC Androgenic Alopecia Therapeutics Forecast
10.1.4 Europe Androgenic Alopecia Therapeutics Forecast
10.1.5 Middle East & Africa Androgenic Alopecia Therapeutics Forecast
10.2 Americas Androgenic Alopecia Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Androgenic Alopecia Therapeutics Market Forecast
10.2.2 Canada Androgenic Alopecia Therapeutics Market Forecast
10.2.3 Mexico Androgenic Alopecia Therapeutics Market Forecast
10.2.4 Brazil Androgenic Alopecia Therapeutics Market Forecast
10.3 APAC Androgenic Alopecia Therapeutics Forecast by Region (2023-2028)
10.3.1 China Androgenic Alopecia Therapeutics Market Forecast
10.3.2 Japan Androgenic Alopecia Therapeutics Market Forecast
10.3.3 Korea Androgenic Alopecia Therapeutics Market Forecast
10.3.4 Southeast Asia Androgenic Alopecia Therapeutics Market Forecast
10.3.5 India Androgenic Alopecia Therapeutics Market Forecast
10.3.6 Australia Androgenic Alopecia Therapeutics Market Forecast
10.4 Europe Androgenic Alopecia Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Androgenic Alopecia Therapeutics Market Forecast
10.4.2 France Androgenic Alopecia Therapeutics Market Forecast
10.4.3 UK Androgenic Alopecia Therapeutics Market Forecast
10.4.4 Italy Androgenic Alopecia Therapeutics Market Forecast
10.4.5 Russia Androgenic Alopecia Therapeutics Market Forecast
10.5 Middle East & Africa Androgenic Alopecia Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Androgenic Alopecia Therapeutics Market Forecast
10.5.2 South Africa Androgenic Alopecia Therapeutics Market Forecast
10.5.3 Israel Androgenic Alopecia Therapeutics Market Forecast
10.5.4 Turkey Androgenic Alopecia Therapeutics Market Forecast
10.5.5 GCC Countries Androgenic Alopecia Therapeutics Market Forecast
10.6 Global Androgenic Alopecia Therapeutics Forecast by Type (2023-2028)
10.7 Global Androgenic Alopecia Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Androgenic Alopecia Therapeutics Product Offered
11.1.3 Johnson & Johnson Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Androgenic Alopecia Therapeutics Product Offered
11.2.3 Merck Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Androgenic Alopecia Therapeutics Product Offered
11.3.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Information
11.4.2 Astellas Pharma Androgenic Alopecia Therapeutics Product Offered
11.4.3 Astellas Pharma Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Astellas Pharma Main Business Overview
11.4.5 Astellas Pharma Latest Developments
11.5 Cipla
11.5.1 Cipla Company Information
11.5.2 Cipla Androgenic Alopecia Therapeutics Product Offered
11.5.3 Cipla Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Cipla Main Business Overview
11.5.5 Cipla Latest Developments
11.6 Almirall
11.6.1 Almirall Company Information
11.6.2 Almirall Androgenic Alopecia Therapeutics Product Offered
11.6.3 Almirall Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Almirall Main Business Overview
11.6.5 Almirall Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma Androgenic Alopecia Therapeutics Product Offered
11.7.3 Sun Pharma Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 Reddy's Laboratories
11.8.1 Reddy's Laboratories Company Information
11.8.2 Reddy's Laboratories Androgenic Alopecia Therapeutics Product Offered
11.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Reddy's Laboratories Main Business Overview
11.8.5 Reddy's Laboratories Latest Developments
11.9 Concert Pharmaceuticals
11.9.1 Concert Pharmaceuticals Company Information
11.9.2 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product Offered
11.9.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Concert Pharmaceuticals Main Business Overview
11.9.5 Concert Pharmaceuticals Latest Developments
11.10 RiverTown Therapeutics
11.10.1 RiverTown Therapeutics Company Information
11.10.2 RiverTown Therapeutics Androgenic Alopecia Therapeutics Product Offered
11.10.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 RiverTown Therapeutics Main Business Overview
11.10.5 RiverTown Therapeutics Latest Developments
11.11 Brickell Biotech
11.11.1 Brickell Biotech Company Information
11.11.2 Brickell Biotech Androgenic Alopecia Therapeutics Product Offered
11.11.3 Brickell Biotech Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Brickell Biotech Main Business Overview
11.11.5 Brickell Biotech Latest Developments
11.12 BiologicsMD
11.12.1 BiologicsMD Company Information
11.12.2 BiologicsMD Androgenic Alopecia Therapeutics Product Offered
11.12.3 BiologicsMD Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 BiologicsMD Main Business Overview
11.12.5 BiologicsMD Latest Developments
11.13 Aclaris Therapeutics
11.13.1 Aclaris Therapeutics Company Information
11.13.2 Aclaris Therapeutics Androgenic Alopecia Therapeutics Product Offered
11.13.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Aclaris Therapeutics Main Business Overview
11.13.5 Aclaris Therapeutics Latest Developments
12 Research Findings and Conclusion
Table 1. Androgenic Alopecia Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Medicine
Table 3. Major Players of Surgery
Table 4. Major Players of Other
Table 5. Androgenic Alopecia Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Androgenic Alopecia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Androgenic Alopecia Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Androgenic Alopecia Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Androgenic Alopecia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Androgenic Alopecia Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Androgenic Alopecia Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Androgenic Alopecia Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Androgenic Alopecia Therapeutics Key Players Head office and Products Offered
Table 14. Androgenic Alopecia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Androgenic Alopecia Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Androgenic Alopecia Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Androgenic Alopecia Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Androgenic Alopecia Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Androgenic Alopecia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Androgenic Alopecia Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Androgenic Alopecia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Androgenic Alopecia Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Androgenic Alopecia Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Androgenic Alopecia Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Androgenic Alopecia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Androgenic Alopecia Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Androgenic Alopecia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Androgenic Alopecia Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Androgenic Alopecia Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Androgenic Alopecia Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Androgenic Alopecia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Androgenic Alopecia Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Androgenic Alopecia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Androgenic Alopecia Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Androgenic Alopecia Therapeutics
Table 44. Key Market Challenges & Risks of Androgenic Alopecia Therapeutics
Table 45. Key Industry Trends of Androgenic Alopecia Therapeutics
Table 46. Global Androgenic Alopecia Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Androgenic Alopecia Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Androgenic Alopecia Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Androgenic Alopecia Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Androgenic Alopecia Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Androgenic Alopecia Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Johnson & Johnson Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 53. Johnson & Johnson Androgenic Alopecia Therapeutics Product Offered
Table 54. Johnson & Johnson Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Johnson & Johnson Main Business
Table 56. Johnson & Johnson Latest Developments
Table 57. Merck Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 58. Merck Androgenic Alopecia Therapeutics Product Offered
Table 59. Merck Main Business
Table 60. Merck Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Merck Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 63. GlaxoSmithKline Androgenic Alopecia Therapeutics Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Astellas Pharma Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 68. Astellas Pharma Androgenic Alopecia Therapeutics Product Offered
Table 69. Astellas Pharma Main Business
Table 70. Astellas Pharma Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Astellas Pharma Latest Developments
Table 72. Cipla Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 73. Cipla Androgenic Alopecia Therapeutics Product Offered
Table 74. Cipla Main Business
Table 75. Cipla Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Cipla Latest Developments
Table 77. Almirall Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 78. Almirall Androgenic Alopecia Therapeutics Product Offered
Table 79. Almirall Main Business
Table 80. Almirall Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Almirall Latest Developments
Table 82. Sun Pharma Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 83. Sun Pharma Androgenic Alopecia Therapeutics Product Offered
Table 84. Sun Pharma Main Business
Table 85. Sun Pharma Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sun Pharma Latest Developments
Table 87. Reddy's Laboratories Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 88. Reddy's Laboratories Androgenic Alopecia Therapeutics Product Offered
Table 89. Reddy's Laboratories Main Business
Table 90. Reddy's Laboratories Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Reddy's Laboratories Latest Developments
Table 92. Concert Pharmaceuticals Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 93. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product Offered
Table 94. Concert Pharmaceuticals Main Business
Table 95. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Concert Pharmaceuticals Latest Developments
Table 97. RiverTown Therapeutics Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 98. RiverTown Therapeutics Androgenic Alopecia Therapeutics Product Offered
Table 99. RiverTown Therapeutics Main Business
Table 100. RiverTown Therapeutics Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. RiverTown Therapeutics Latest Developments
Table 102. Brickell Biotech Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 103. Brickell Biotech Androgenic Alopecia Therapeutics Product Offered
Table 104. Brickell Biotech Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Brickell Biotech Main Business
Table 106. Brickell Biotech Latest Developments
Table 107. BiologicsMD Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 108. BiologicsMD Androgenic Alopecia Therapeutics Product Offered
Table 109. BiologicsMD Main Business
Table 110. BiologicsMD Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. BiologicsMD Latest Developments
Table 112. Aclaris Therapeutics Details, Company Type, Androgenic Alopecia Therapeutics Area Served and Its Competitors
Table 113. Aclaris Therapeutics Androgenic Alopecia Therapeutics Product Offered
Table 114. Aclaris Therapeutics Main Business
Table 115. Aclaris Therapeutics Androgenic Alopecia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Aclaris Therapeutics Latest Developments
List of Figures
Figure 1. Androgenic Alopecia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Androgenic Alopecia Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Androgenic Alopecia Therapeutics Market Size Market Share by Type in 2021
Figure 7. Androgenic Alopecia Therapeutics in Hospital
Figure 8. Global Androgenic Alopecia Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Androgenic Alopecia Therapeutics in Clinic
Figure 10. Global Androgenic Alopecia Therapeutics Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Androgenic Alopecia Therapeutics in Other
Figure 12. Global Androgenic Alopecia Therapeutics Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Androgenic Alopecia Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Androgenic Alopecia Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Androgenic Alopecia Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Androgenic Alopecia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Androgenic Alopecia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Androgenic Alopecia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Androgenic Alopecia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Androgenic Alopecia Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Androgenic Alopecia Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Androgenic Alopecia Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Androgenic Alopecia Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Androgenic Alopecia Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Androgenic Alopecia Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Androgenic Alopecia Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Androgenic Alopecia Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Androgenic Alopecia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Androgenic Alopecia Therapeutics Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...